genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Human cytomegalovirus
Cancer
Harnessing the Power of g-NK Cells to Treat Hematologic Malignancies
Cancer
What’s Next for mRNA Vaccines?
Bioprocessing
Gene Therapy Turns to the Use of Synthetic Biology Principles
Drug Discovery
Immune Surrogate Finding May Accelerate CMV Vaccine Development
Featured
Cytomegalovirus’ Immune Evasion Tactics Uncovered
Drug Discovery
mRNA-Based Drugs Prepare to Go the Distance
Drug Discovery
Immunomic Licenses CMV-Targeting Tech from Annias for LAMP-Vax Cancer Vaccines
Cancer
Brain Cancer Vaccine–Chemotherapy Combo Shows Promise
Drug Discovery
Positive Phase III Data for Merck Candidates against CMV and Shingles
Drug Discovery
Chimerix Axes 20% of Workforce, Citing Phase III Failure
1
2
3
4
Page 1 of 4
Scroll Up
Scroll Up
